Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-10

Clinical Trial Update: Ipilimumab + Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ipilimumab plus nivolumab with cryotherapy in soft tissue sarcoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cryotherapy
  • ipilimumab (ipilimumab)
  • nivolumab (nivolumab)

Snippet

Sponsor: Kristen Ganjoo | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2022-10-10